Clinical trial
Transvaginal Treatment of Anterior and Apical Genital Prolapses Using an Ultra Lightweight Mesh: Restorelle® Direct FixTM: a Retrospective Study on Feasibility and Morbidity.
NCT03098641 is registered in ClinicalTrials.gov with Groupe Hospitalier de la Rochelle Ré Aunis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transvaginal Treatment of Anterior and Apical Genital Prolapses Using an Ultra Lightweight Mesh: Restorelle® Direct FixTM: a Retrospective Study on Feasibility and Morbidity.
- Lead sponsor
- Groupe Hospitalier de la Rochelle Ré Aunis
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2017
- Completion date
- September 26, 2017
- Enrollment
- 272 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.